4TOS | Crystal structure of Tankyrase 1 with 355 | date | |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Chen, H., Zhang, X., Lum, l., Chen, C. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.80 | ||||||||||||
ligand | 355, ZN | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Disruption of Wnt/beta-catenin signaling and telomeric shortening are inextricable consequences of tankyrase inhibition in human cells., Kulak O, Chen H, Holohan B, Wu X, He H, Borek D, Otwinowski Z, Yamaguchi K, Garofalo LA, Ma Z, Wright W, Chen C, Shay JW, Zhang X, Lum L, Mol Cell Biol. 2015 May 4. pii: MCB.00392-15. PMID:25939383 |
Data retrieval |
View 4TOS in 3D |
Visual 3D analysis of 4TOS |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4TOS |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |